Lack of interaction between ErbB2 and insulin receptor substrate signaling in breast cancer

被引：0
|
作者：
Susan M. Farabaugh
Bonita T. Chan
Xiaojiang Cui
Robert K. Dearth
Adrian V. Lee
机构：
[1] University of Pittsburgh Cancer Institute,Women’s Cancer Research Center, Department of Pharmacology and Chemical Biology
[2] Magee Women’s Research Institute,Lester and Sue Smith Breast Center, Department of Molecular and Cellular Biology
[3] Baylor College of Medicine,undefined
来源：
Cell Communication and Signaling | / 14卷
关键词：
IRS; ErbB2; Breast cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] A monoclonal antibody targeting ErbB2 domain III inhibits ErbB2 signaling and suppresses the growth of ErbB2-overexpressing breast tumors
    Meng, Y.
    Zheng, L.
    Yang, Y.
    Wang, H.
    Dong, J.
    Wang, C.
    Zhang, Y.
    Yu, X.
    Wang, L.
    Xia, T.
    Zhang, D.
    Guo, Y.
    Li, B.
    ONCOGENESIS, 2016, 5 : e211 - e211
  • [32] Modulation of Erbb2 signaling during development: a threshold level of Erbb2 signaling is required for development
    Chan, R
    Hardy, WR
    Dankort, D
    Laing, MA
    Muller, WJ
    DEVELOPMENT, 2004, 131 (22): : 5551 - 5560
  • [33] Identification of a small peptide that inhibits the phosphorylation of ErbB2 and proliferation of ErbB2 overexpressing breast cancer cells
    Pero, SC
    Shukla, GS
    Armstrong, AL
    Peterson, D
    Fuller, SP
    Godin, K
    Kingsley-Richards, SL
    Weaver, DL
    Bond, J
    Krag, DN
    INTERNATIONAL JOURNAL OF CANCER, 2004, 111 (06) : 951 - 960
  • [34] ErbB2 Signaling Increases Androgen Receptor Expression in Abiraterone-Resistant Prostate Cancer
    Gao, Shuai
    Ye, Huihui
    Gerrin, Sean
    Wang, Hongyun
    Sharma, Ankur
    Chen, Sen
    Patnaik, Akash
    Sowalsky, Adam G.
    Voznesensky, Olga
    Han, Wanting
    Yu, Ziyang
    Mostaghel, Elahe A.
    Nelson, Peter S.
    Taplin, Mary-Ellen
    Balk, Steven P.
    Cai, Changmeng
    CLINICAL CANCER RESEARCH, 2016, 22 (14) : 3672 - 3682
  • [35] A systematic understanding of signaling by ErbB2 in cancer using phosphoproteomics
    Sidhanth, C.
    Manasa, P.
    Krishnapriya, S.
    Sneha, S.
    Bindhya, S.
    Nagare, R. P.
    Garg, M.
    Ganesan, T. S.
    BIOCHEMISTRY AND CELL BIOLOGY, 2018, 96 (03) : 295 - 305
  • [36] Ethanol Enhances the Interaction of Breast Cancer Cells Over-Expressing ErbB2 With Fibronectin
    Xu, Mei
    Bower, Kimberly A.
    Chen, Gang
    Shi, Xianglin
    Dong, Zheng
    Ke, Zunji
    Luo, Jia
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2010, 34 (05) : 751 - 760
  • [37] A phosphoproteomic analysis of the ErbB2 receptor tyrosine kinase signaling pathways
    Mukherji, Mridul
    Brill, Laurence M.
    Ficarro, Scott B.
    Hampton, Garret M.
    Schultz, Peter G.
    BIOCHEMISTRY, 2006, 45 (51) : 15529 - 15540
  • [38] Regulation of survivin by ErbB2 signaling: Therapeutic implications for ErbB2-overexpressing breast cancers
    Xia, WL
    Bisi, J
    Strum, J
    Liu, LH
    Carrick, K
    Graham, KM
    Treece, AL
    Hardwicke, MA
    Dush, M
    Liao, QY
    Westlund, RE
    Zhao, SM
    Bacus, S
    Spector, NL
    CANCER RESEARCH, 2006, 66 (03) : 1640 - 1647
  • [39] Receptor tyrosine kinase ERBB4 mediates acquired resistance to ERBB2 inhibitors in breast cancer cells
    Canfield, Kaleigh
    Li, Jiaqi
    Wilkins, Owen M.
    Morrison, Meghan M.
    Ung, Matthew
    Wells, Wendy
    Williams, Charlotte R.
    Liby, Karen T.
    Vullhorst, Detlef
    Buonanno, Andres
    Hu, Huizhong
    Schiff, Rachel
    Cook, Rebecca S.
    Kurokawa, Manabu
    CELL CYCLE, 2015, 14 (04) : 648 - 655
  • [40] The chromodomain helicase CHD4 regulates ERBB2 signaling pathway and autophagy in ERBB2+ breast cancer cells
    D'Alesio, Carolina
    Bellese, Grazia
    Gagliani, Maria Cristina
    Lechiara, Anastasia
    Dameri, Martina
    Grasselli, Elena
    Lanfrancone, Luisa
    Cortese, Katia
    Castagnola, Patrizio
    BIOLOGY OPEN, 2019, 8 (04):
12345